In FHS, lower blood DNA methylation at both cg12729894 (MOB2/CTSD) and cg15150970 (DNMT3A) is suggestively associated with greater risk of AD (P = 0.007), Table 3. This evidence concerns the gene CTSD and Floating-Harbor syndrome.